Lyell Immunopharma, Inc. (LYEL) stock
LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.89+0.22 (+1.61%)
Close on Nov 18, 2026Market cap $340.38MP/E –Yield –
Lyell Immunopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lyell Immunopharma's market cap was $394.47M on Nov 11, 2026, against $463.05M a year earlier. Over the last 5 years it ranged from $128.95M to $1.86B, with a median of $463.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $394.47M | -33.6% |
| 2025 | Dec 31, 2025 | $593.87M | +261.7% |
| 2024 | Dec 31, 2024 | $164.20M | -66.4% |
| 2023 | Dec 29, 2023 | $488.63M | -43.5% |
| 2022 | Dec 30, 2022 | $864.86M | -53.4% |
| 2021 | Dec 31, 2021 | $1.86B | – |
See a number that looks wrong?